Anima Ghosal

1.2k total citations
28 papers, 946 citations indexed

About

Anima Ghosal is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Anima Ghosal has authored 28 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Anima Ghosal's work include Pharmacogenetics and Drug Metabolism (18 papers), Drug Transport and Resistance Mechanisms (8 papers) and Analytical Chemistry and Chromatography (5 papers). Anima Ghosal is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Drug Transport and Resistance Mechanisms (8 papers) and Analytical Chemistry and Chromatography (5 papers). Anima Ghosal collaborates with scholars based in United States, China and Bulgaria. Anima Ghosal's co-authors include Swapan K. Chowdhury, Kevin B. Alton, Shmuel Zbáida, James E. Patrick, Ernie D. Bush, Thomas K. H. Chang, D. Moore, Robert Iannucci, Yuan Yuan and Yuan Yuan and has published in prestigious journals such as Archives of Biochemistry and Biophysics, Biochemical Pharmacology and Cancer Letters.

In The Last Decade

Anima Ghosal

28 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anima Ghosal United States 16 446 273 224 165 121 28 946
Masako Ohno Japan 13 491 1.1× 191 0.7× 185 0.8× 204 1.2× 142 1.2× 22 797
Huy Riêm Ha Switzerland 16 504 1.1× 482 1.8× 246 1.1× 258 1.6× 93 0.8× 21 1.3k
Stephen P Adams Canada 19 344 0.8× 190 0.7× 386 1.7× 111 0.7× 102 0.8× 36 1.4k
H. Heidemann Germany 16 374 0.8× 292 1.1× 106 0.5× 188 1.1× 115 1.0× 48 979
Toshifumi Shiraga Japan 21 554 1.2× 300 1.1× 349 1.6× 232 1.4× 87 0.7× 59 1.4k
Caroline A. Lee United States 19 691 1.5× 590 2.2× 277 1.2× 166 1.0× 121 1.0× 27 1.4k
M B Faletto United States 11 621 1.4× 324 1.2× 444 2.0× 407 2.5× 128 1.1× 18 1.4k
Brian Ethell United Kingdom 16 458 1.0× 299 1.1× 376 1.7× 81 0.5× 69 0.6× 26 1.1k
Justin D. Lutz United States 16 294 0.7× 219 0.8× 252 1.1× 154 0.9× 63 0.5× 21 838
Gloria Y. Kwei United States 14 348 0.8× 324 1.2× 339 1.5× 139 0.8× 35 0.3× 28 1.2k

Countries citing papers authored by Anima Ghosal

Since Specialization
Citations

This map shows the geographic impact of Anima Ghosal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anima Ghosal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anima Ghosal more than expected).

Fields of papers citing papers by Anima Ghosal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anima Ghosal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anima Ghosal. The network helps show where Anima Ghosal may publish in the future.

Co-authorship network of co-authors of Anima Ghosal

This figure shows the co-authorship network connecting the top 25 collaborators of Anima Ghosal. A scholar is included among the top collaborators of Anima Ghosal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anima Ghosal. Anima Ghosal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Xiaoyan, Xiaoxin Cai, Donghui Cui, et al.. (2013). In Vitro Assessment of Drug-Drug Interaction Potential of Boceprevir Associated with Drug Metabolizing Enzymes and Transporters. Drug Metabolism and Disposition. 41(3). 668–681. 48 indexed citations
2.
Ghosal, Anima, Yuan Yuan, Wei Tong, et al.. (2010). Characterization of Human Liver Enzymes Involved in the Biotransformation of Boceprevir, a Hepatitis C Virus Protease Inhibitor. Drug Metabolism and Disposition. 39(3). 510–521. 53 indexed citations
3.
Ghosal, Anima, Xiaowen Lu, Natalia A. Penner, et al.. (2010). Identification of Human Liver Cytochrome P450 Enzymes Involved in the Metabolism of SCH 530348 (Vorapaxar), a Potent Oral Thrombin Protease-Activated Receptor 1 Antagonist. Drug Metabolism and Disposition. 39(1). 30–38. 44 indexed citations
5.
Ghosal, Anima, Samir K. Gupta, Ragu Ramanathan, et al.. (2009). Metabolism of Loratadine and Further Characterization of Its In Vitro Metabolites. Drug Metabolism Letters. 3(3). 162–170. 34 indexed citations
6.
Ghosal, Anima, Ragu Ramanathan, Yuan Yuan, et al.. (2007). Identification of Human Liver Cytochrome P450 Enzymes Involved in Biotransformation of Vicriviroc, a CCR5 Receptor Antagonist. Drug Metabolism and Disposition. 35(12). 2186–2195. 19 indexed citations
7.
Ghosal, Anima, et al.. (2006). IDENTIFICATION OF HUMAN LIVER CYTOCHROME P450 ENZYMES RESPONSIBLE FOR THE METABOLISM OF LONAFARNIB (SARASAR). Drug Metabolism and Disposition. 34(4). 628–635. 22 indexed citations
9.
Ghosal, Anima, Yuan Yuan, Robert Iannucci, et al.. (2004). IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL). Drug Metabolism and Disposition. 32(2). 267–271. 139 indexed citations
10.
Ghosal, Anima, Yuan Yuan, Robert Iannucci, et al.. (2004). IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF EZETIMIBE (ZETIA). Drug Metabolism and Disposition. 32(3). 314–320. 108 indexed citations
11.
Ghosal, Anima, Yuan Yuan, Swapan K. Chowdhury, et al.. (2004). Identification of human UDP‐glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3‐hydroxydesloratadine. Biopharmaceutics & Drug Disposition. 25(6). 243–252. 30 indexed citations
12.
Ghosal, Anima, et al.. (2003). Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes. Biopharmaceutics & Drug Disposition. 24(9). 375–384. 63 indexed citations
13.
Iba, Michael M., et al.. (2003). Constitutive and inducible levels of CYP1A1 and CYP1A2 in rat cerebral cortex and cerebellum. Archives of Toxicology. 77(10). 547–554. 28 indexed citations
14.
Iba, Michael M., Anima Ghosal, & Robert Snyder. (2001). Comparative metabolism of [ 14 C]benzene to excretable products and bioactivation to DNA-binding derivatives in maternal and neonatal mice. Archives of Toxicology. 75(10). 574–582. 2 indexed citations
15.
Iba, Michael M., Jawed Alam, Cheri Touchard, et al.. (1999). Coordinate up-regulation of CYP1A1 and heme oxygenase-1 (HO-1) expression and modulation of δ-aminolevulinic acid synthase and tryptophan pyrrolase activities in pyridine-treated rats. Biochemical Pharmacology. 58(4). 723–734. 18 indexed citations
16.
Ghosal, Anima, Nakissa Sadrieh, Linda M. Reik, Wayne Levin, & Paul E. Thomas. (1996). Induction of the Male-Specific Cytochrome P450 3A2 in Female Rats by Phenytoin. Archives of Biochemistry and Biophysics. 332(1). 153–162. 40 indexed citations
17.
Iba, Michael M., et al.. (1993). Synergistic induction of rat microsomal CYP1A1 and CYP1A2 by acetone in combination with pyridine. Cancer Letters. 74(1-2). 69–74. 18 indexed citations
18.
Ghosal, Anima & Michael M. Iba. (1992). Enhancement by butylated hydroxytoluene of the in vitro activation of 3,3'-dichlorobenzidne. Mutation Research/Genetic Toxicology. 278(1). 31–41. 7 indexed citations
19.
Iba, Michael M., et al.. (1990). Covalent interaction of 3,3'-dichlorobenzidine with hepatic lipids. Biochemical Pharmacology. 40(3). 581–587. 2 indexed citations
20.
Ghosal, Anima & Michael M. Iba. (1990). In vivo binding of 3,3′-dichlorobenzidine to rat and mouse tissue DNA. Cancer Letters. 53(2-3). 197–204. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026